Cargando…

Nobiletin ameliorates high fat-induced disruptions in rhythmic glucagon-like peptide-1 secretion

The incretin hormone glucagon-like peptide-1 (GLP-1) is secreted by the intestinal L cell in response to nutrient intake. However, GLP-1 secretion also follows a circadian rhythm which is disrupted by the saturated fatty acid palmitate in vitro and high-fat diet (HFD) feeding in vivo. The flavonoid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martchenko, Alexandre, Biancolin, Andrew D., Martchenko, Sarah E., Brubaker, Patricia L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068808/ https://www.ncbi.nlm.nih.gov/pubmed/35508494 http://dx.doi.org/10.1038/s41598-022-11223-7

Ejemplares similares

L-cell Arntl is required for rhythmic glucagon-like peptide-1 secretion and maintenance of intestinal homeostasis
por: Martchenko, Sarah E., et al.
Publicado: (2021)

Inflaming the Clock: Effects of Interleukin 1β on Circadian Rhythmicity of Pancreatic β Cells
por: Martchenko, Alexandre, et al.
Publicado: (2020)

Essential Role of Syntaxin-Binding Protein-1 in the Regulation of Glucagon-Like Peptide-1 Secretion
por: Campbell, Jhenielle R, et al.
Publicado: (2020)

The core clock gene, Bmal1, and its downstream target, the SNARE regulatory protein secretagogin, are necessary for circadian secretion of glucagon-like peptide-1
por: Biancolin, Andrew D., et al.
Publicado: (2019)

Effects of Obesogenic Feeding and Free Fatty Acids on Circadian Secretion of Metabolic Hormones: Implications for the Development of Type 2 Diabetes
por: Martchenko, Alexandre, et al.
Publicado: (2021)

Diurnal changes in the murine small intestine are disrupted by obesogenic Western Diet feeding and microbial dysbiosis
por: Martchenko, Sarah E., et al.
Publicado: (2021)

SUN-LB018 Role of BMAL1 in Western Diet-Induced Disruption of Circadian Hypothalamic Feeding Neuropeptides
por: Clemenzi, Matthew, et al.
Publicado: (2019)

Glucagon‐like peptide‐1: The missing link in the metabolic clock?
por: Brubaker, Patricia L, et al.
Publicado: (2016)

GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
por: Lauffer, Lina M., et al.
Publicado: (2009)

The roles of glucagon-like peptide-2 and the intestinal epithelial insulin-like growth factor-1 receptor in regulating microvillus length
por: Markovic, Melanie A., et al.
Publicado: (2019)

Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1
por: Wang, XingChun, et al.
Publicado: (2015)

Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid
por: Fernandes, Maria F., et al.
Publicado: (2022)

Glucagon-Like Peptide-2 Stimulates S-Phase Entry of Intestinal Lgr5+ Stem Cells
por: Chen, Maegan E., et al.
Publicado: (2022)

Chicken Intestinal L Cells and Glucagon-like Peptide-1 Secretion
por: Hiramatsu, Kohzy
Publicado: (2020)

Delphinidin 3‐rutinoside‐rich blackcurrant extract ameliorates glucose tolerance by increasing the release of glucagon‐like peptide‐1 secretion
por: Tani, Tsubasa, et al.
Publicado: (2017)

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
por: Sawada, Noritaka, et al.
Publicado: (2020)

Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review
por: Bodnaruc, Alexandra M., et al.
Publicado: (2016)

Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice
por: Lindqvist, Andreas, et al.
Publicado: (2017)

Direct visualization of glucagon‐like peptide‐1 secretion by fluorescent fusion proteins
por: Tsuzuki, Atsushi, et al.
Publicado: (2022)

Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
por: Tan, Tricia M., et al.
Publicado: (2013)

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus
por: Patel, Vishal J, et al.
Publicado: (2018)

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
por: Kim, Kevin, et al.
Publicado: (2015)

Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
por: Hong, Yeonhee, et al.
Publicado: (2019)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Modulation of Fat Deposition–Gut Interactions in Obese Mice by Administrating with Nobiletin
por: Zhao, Cunzhen, et al.
Publicado: (2023)

Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans
por: Welch, Andrew A., et al.
Publicado: (2023)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion
por: Reimann, Frank, et al.
Publicado: (2016)

Carbohydrate‐induced secretion of glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1
por: Seino, Yusuke, et al.
Publicado: (2016)

Laminarin counteracts diet-induced obesity associated with glucagon-like peptide-1 secretion
por: Yang, Liusong, et al.
Publicado: (2017)

New concept of the glucagon‐like peptide‐1 signaling pathway on pancreatic insulin secretion
por: Kaku, Kohei
Publicado: (2019)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
por: Ammann, Markus, et al.
Publicado: (2023)

Abscisic Acid Stimulates Glucagon-Like Peptide-1 Secretion from L-Cells and Its Oral Administration Increases Plasma Glucagon-Like Peptide-1 Levels in Rats
por: Bruzzone, Santina, et al.
Publicado: (2015)

Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011)

An Association between Decreased Small Intestinal RNA Modification and Disturbed Glucagon-like Peptide-1 Secretion under High-Fat Diet Stress
por: Chen, Jiang, et al.
Publicado: (2023)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Glucagon-like peptide 1 and Glucagon-like peptide 2 in relation to osteoporosis in non-diabetic postmenopausal women
por: Montes Castillo, María Cristina, et al.
Publicado: (2019)

Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate intestinal enterocytes and afferent neurons
por: Lu, Van B., et al.
Publicado: (2019)

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
por: Mulvihill, Erin E.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vicotilmb6houbhjptueh56rj8